250 related articles for article (PubMed ID: 26137657)
1. Human Herpes Virus-6 Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Shachor-Meyouhas Y; Fesenko A; Kra-Oz Z; Zaidman I; Szwarcwort-Cohen M; Shafran E; Kassis I
Isr Med Assoc J; 2015 May; 17(5):302-5. PubMed ID: 26137657
[TBL] [Abstract][Full Text] [Related]
2. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
3. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
4. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
[TBL] [Abstract][Full Text] [Related]
10. HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR.
Inazawa N; Hori T; Yamamoto M; Hatakeyama N; Yoto Y; Nojima M; Yasui H; Suzuki N; Shimizu N; Tsutsumi H
J Med Virol; 2016 Feb; 88(2):319-23. PubMed ID: 26241219
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
12. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation.
Violago L; Jin Z; Bhatia M; Rustia E; Kung AL; Foca MD; George D; Garvin JH; Sosna J; Robinson C; Karamehmet E; Satwani P
Pediatr Transplant; 2015 Nov; 19(7):737-44. PubMed ID: 26329541
[TBL] [Abstract][Full Text] [Related]
14. Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
Perissinotti AJ; Gulbis A; Shpall EJ; Howell J
J Oncol Pharm Pract; 2015 Apr; 21(2):85-92. PubMed ID: 24407957
[TBL] [Abstract][Full Text] [Related]
15. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus-6 and -7 in pediatric stem cell transplantation.
Savolainen H; Lautenschlager I; Piiparinen H; Saarinen-Pihkala U; Hovi L; Vettenranta K
Pediatr Blood Cancer; 2005 Nov; 45(6):820-5. PubMed ID: 15700258
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
Zerr DM; Corey L; Kim HW; Huang ML; Nguy L; Boeckh M
Clin Infect Dis; 2005 Apr; 40(7):932-40. PubMed ID: 15824982
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
